Re-linkage to Care of Patients With Hepatitis C

Viral Hepatitis C Clinical Trial

Official title:

Effectiveness of Implementing a Strategy to Re-linkage to Care of Patients With Hepatitis C Who Were Lost to Follow-up

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04470271
• Other study ID #: CIE N° P 20-008
• Status: Not yet recruiting
• Start date: September 1, 2020
• Est. completion date: March 31, 2021

Study information

• Verified date: July 2020
• Source: Austral University, Argentina
• Contact: Manuel Mendizabal, MD
• Phone: +5491140332244
• Email: mmendiza[@]cas.austral.edu.ar
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to identify patients with chronic hepatitis C virus (HCV) who were lost of follow up and relinkage them to hepatitis C care

Description:

The investigators will review electronic medical charts to identify patients with HCV diagnosis. Next, investigators will evaluate if these patients are routinely followed by liver specialists at the Institution. Those patients who were lost of follow up will be reached to evaluate their disease and eventually offer them to restart HCV care.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1000
• Est. completion date: March 31, 2021
• Est. primary completion date: December 31, 2020
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients older than 18 years

• Patients clinically evaluated at least once in the participating medical center

• chronic HCV infection

Exclusion Criteria:

• There are no exclusion criteria

Related Conditions & MeSH terms

• Hepatitis
• Hepatitis A
• Hepatitis C
• Viral Hepatitis C

Intervention

Other:
• Patients with hepatitis C lost follow up
Patients with chronic HCV who were lost of follow up will be contacted by phone or email. At least 3 phone calls will be made on three different days. In case the patient is not contacted it will be considered lost of follow-up

Locations

Country	Name	City	State
Argentina	Universidad Austral	Pilar	Buenos Aires

Sponsors (1)

Lead Sponsor	Collaborator
Austral University, Argentina

Country where clinical trial is conducted

Argentina, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants who were lost of follow up	Participants are going to be contacted by phone or email to evaluate if they are under HCV care	through study completion, an average of 6 months